Cadila Healthcare Gets DCGI Nod to Conduct Phase III Trials for Two-dose Covid Vaccine

. The company has already received the emergency use authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D to be administered in three doses on August 20.

Source: Top India News- News18.com